Stringer Asset Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Stringer Asset Management’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-22,593	Closed	-$1.12M	–	32
2015 Q3	$1.12M	Buy	22,593 +819	+4%	+$46.9K	1.36%	19
2015 Q2	$1.27M	Buy	21,774 +3,345	+18%	+$195K	1.33%	20
2015 Q1	$1.06M	Buy	18,429 +597	+3%	+$32.7K	1.21%	19
2014 Q4	$900K	Buy	17,832 +279	+2%	+$13.6K	1.15%	19
2014 Q3	$821K	Sell	17,553 -100,743	-85%	-$4.55M	1.2%	21
2014 Q2	$5.33M	Sell	118,296 -14,442	-11%	-$621K	3.3%	14
2014 Q1	$5.61M	Buy	+132,738	New	+$5.56M	4.25%	13

Other funds holding IHE

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

SPC Financial Inc Rockville, Maryland $1.28B AUM 12.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Stringer Asset Management's IHE Position: Q4 2015 in Review

Stringer Asset Management sold out of iShares US Pharmaceuticals ETF (IHE) in Q4 2015, closing a stake of 22,593 shares — an estimated $1.12M sold.

Stringer Asset Management first reported a position in IHE in Q1 2014 and held it in 7 quarters. The position peaked at $5.61M in Q1 2014. 103 funds tracked by Wall St. Rank hold IHE as of Q4 2015.

Stringer Asset Management reported no remaining iShares US Pharmaceuticals ETF position as of Q4 2015 after selling out during the quarter.
Stringer Asset Management sold 22,593 iShares US Pharmaceuticals ETF shares in Q4 2015, an estimated $1.12M.
Stringer Asset Management first reported a position in iShares US Pharmaceuticals ETF in Q1 2014 and held it in 7 quarters.
Stringer Asset Management's iShares US Pharmaceuticals ETF position peaked at $5.61M in Q1 2014.
103 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2015.

Based on Stringer Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.